UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
|
Date of Report (Date of earliest event reported)
|
|
|
|
|
|
i NU SKIN ENTERPRISES, INC.
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
i Delaware
|
|
|
|
i 87-0565309
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
|
i 75 West Center Street
i Provo, i Utah i 84601
|
|
|
(Address of principal executive offices and zip code)
|
|
|
|
|
|
( i 801) i 345-1000
|
|
|
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
N/A
|
|
|
(Former name or former address, if changed since last report)
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the
following provisions:
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
i ☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
i ☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
i ☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
i Class A Common Stock, $.001 par value
|
i NUS
|
i New York Stock Exchange
|
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use
the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. |
Entry into a Material Definitive Agreement.
|
On
June 14, 2022 (the
“Closing Date”), Nu Skin Enterprises, Inc. (the
“Company”) entered into an Amended and Restated Credit Agreement (the
“Credit Agreement”) by and among
the Company, as Borrower, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent, which amends and restates
the Company’s existing credit agreement, dated as of
April 18, 2018. The Credit Agreement provides for
a $400 million term loan facility and a $500 million revolving credit facility, each with a term of five years. On the Closing Date,
the Company drew the term loan facility in full, and it drew $30 million on the revolving credit facility. The
proceeds of the credit facilities are permitted to be used for working capital, capital expenditures and other lawful general corporate purposes of
the Company.
The Company used all proceeds that were drawn on the Closing Date to repay all amounts
outstanding under its credit agreement dated as of
April 18, 2018.
The revolving credit facility includes a subfacility for swingline loans of up to $20 million, and up to $20 million of the revolving credit facility is available for the
issuance of letters of credit. The term loan facility will amortize in quarterly installments in amounts resulting in an annual amortization of 2.5% during the first year and 5.0% during the second, third, fourth and fifth years after the Closing
Date, with the remainder payable at final maturity. The loans under the Credit Agreement bear interest, at the option of
the Company, either (i) during any interest period selected by
the Company, at the Secured Overnight Financing Rate for deposits
in U.S. dollars with a maturity comparable to such interest period, adjusted for statutory reserves (
“Term SOFR”), plus an initial spread of 1.75% per annum, subject to adjustment based on the consolidated leverage ratio of
the Company, or (ii) at
the greatest of (x) the federal funds effective rate plus 1/2 of 1%, (y) the prime rate from time to time announced by Bank of America, N.A. and (z) Term SOFR for a one-month interest period plus 1.00%, plus an initial spread of 2.00% per annum,
subject to adjustment based on the consolidated leverage ratio of
the Company. If an event of default occurs under the Credit Agreement, the interest rate on overdue amounts will increase by 2.00% per annum. The obligations under the Credit Agreement
are guaranteed by certain domestic
subsidiaries of
the Company (collectively with
the Company, the
“Loan Parties”) and are secured by a lien on the capital stock of material
subsidiaries of the Loan Parties, pursuant to security and guarantee
documents entered into on the Closing Date.
The Credit Agreement requires
the Company to maintain a consolidated leverage ratio not exceeding 2.75 to 1.00 and a consolidated interest coverage ratio of no less than
3.00 to 1.00. The Credit Agreement also includes other covenants, including covenants that, subject to certain exceptions, restrict the ability of
the Company and its
subsidiaries (i) to create, incur, assume or permit to exist any liens, (ii) to
incur additional indebtedness, (iii) to make investments and acquisitions, (iv) to enter into mergers, consolidations or similar transactions, (v) to make certain dispositions of assets, (vi) to make dividends, distributions and prepayments of
certain indebtedness, (vii) to change the nature of
the Company’s business, (viii) to enter into certain transactions with affiliates, (ix) to enter into certain burdensome agreements, (x) to make certain amendments to certain agreements and
organizational documents and (xi) to make certain accounting changes.
The Credit Agreement provides for the following events of default: (i) non-payment by any of the Loan Parties of any principal when due or any interest or fees within five
Business Days of the due date, (ii) the failure by any Loan Party to comply with any covenant or agreement contained in the Credit Agreement or any other loan document, in certain cases subject to notice and lapse of time, (iii) any representation or
warranty pursuant to the Credit Agreement or any other loan document is incorrect in any material respect, (iv) a payment default of the greater of $50 million and 12.5% of Consolidated EBITDA or more under other indebtedness of any Loan Party or any
subsidiary of
the Company that continues beyond any applicable grace period or any other event or condition under such indebtedness occurs that results in, or permits the holder thereof to cause such indebtedness to become immediately due and
payable, (v) certain bankruptcy or insolvency events with respect to any Loan Party or any material subsidiary, (vi) any attachment or similar process issued or levied against any material property and not released within 60 days, (vii) one or more
undischarged judgments for the payment of money in an aggregate amount the greater of $50 million and 12.5% of Consolidated EBITDA or more, (viii) certain events relating to ERISA (Employee Retirement Income Security Act) plans that could reasonably
be expected to result in a material adverse effect, (ix) the invalidity of any material lien or guarantee granted under the loan documents and (x) the occurrence of a change of control. If an event of default occurs and is continuing, the
Administrative Agent may accelerate the amounts and terminate all commitments outstanding under the Credit Agreement and may exercise remedies in respect of the collateral.
From time to time, the Lenders and certain of their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the
ordinary course of business with
the Company. They have received, or may in the future receive, customary fees and commissions for these transactions.
A copy of the Credit Agreement is attached as
Exhibit 10.1 to this Current Report on Form 8-K. Reference is made to the Credit Agreement for its complete terms. The
foregoing description of the Credit Agreement is qualified in its entirety by reference to such exhibit.
Item 2.03. |
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
|
Item 9.01. |
Financial Statements and Exhibits.
|
(d) Exhibits.
|
Amended and Restated Credit Agreement among the Company, various financial institutions, and Bank of America, N.A. as administrative agent, dated as of June 14, 2022
|
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
NU SKIN ENTERPRISES, INC.
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|